Text Size
5 studies found for:    alpharadin | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Study of Alpharadin® With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)
Conditions: Bone Metastases;   Castration-Resistant Prostate Cancer
Interventions: Drug: Alpharadin® (Radium-223 dichloride) + docetaxel;   Drug: Docetaxel
2 Recruiting Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Condition: Prostatic Neoplasms
Intervention: Drug: Radium-223 dichloride (BAY88-8223)
3 Recruiting Radium-223 Dichloride (Ra-223 Cl2) Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis
Condition: Prostatic Neoplasms
Intervention: Drug: Radium-223 dichloride (Xofigo, BAY88-8223)
4 Available Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Condition: Prostatic Neoplasms
Intervention: Drug: Radium-223 dichloride (BAY88-8223)
5 Not yet recruiting Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Condition: Sarcoma
Intervention: Drug: Ra-223 Dichloride
To Top

† Indicates status has not been verified in more than two years